| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $700.0K | $5.9M | $5.5M |
| YoY Revenue Growth % | -88.1% | +6.1% | — |
| Gross Profit | -$5.9M | $1.7M | — |
| Gross Margin % | -50.0% | 28.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$38.4M | -$21.7M | -$29.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$48.9M | -$24.5M | -$27.5M |
| EBITDA (Normalized) | -$35.2M | -$21.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$20.8M | -$18.6M | -$29.8M |
| Capital Expenditures (CapEx) | $4.0M | $505.0K | — |
| Free Cash Flow (FCF) | -$24.8M | -$19.1M | -$29.8M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $7.1M | $10.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $20.1M | $28.9M | — |